BioSpace News Archive

Drug Development

Biophytis Receives a Positive Opinion for its SARA-31 Phase 3 Study in Sarcopenia in Europe

Biophytis SA, announced that it has received a positive opinion from Belgian authorities to conduct its SARA-31 program, which will be the first phase 3 study ever launched in sarcopenia.

August 8, 2023
·
5 min read
Safe Orthopaedics announces the publication of a biomechanical study on Sycamore

Safe, french group specialized in the design, manufacturing and distribution of ready-to-use medical devices for Spine surgeries, especially safe for vertebral fracture treated in emergency, announces the publication of a biomechanical study of Sycamore and over 160 patients treated with Sycamore.

August 8, 2023
·
4 min read
Genetown

Astex Expands Drug Discovery Collaboration With MSD

Astex Pharmaceuticals announced an exclusive worldwide research collaboration and license agreement with MSD.

August 8, 2023
·
2 min read
Business

Harbour BioMed Appoints Dr. Albert R. Collinson as Independent Non-Executive Director

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology announced the appointment of Dr. Albert R. Collinson as independent non-executive director.

August 8, 2023
·
3 min read
BioForest

NanoString to Webcast Presentations from Upcoming Healthcare Conferences

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences.

August 8, 2023
·
2 min read
Business

Science 37 Reports Second Quarter 2023 Financial Results

Science 37 Holdings, Inc., the industry-leading Metasite™, reported its financial results for the quarter ended June 30, 2023.

August 8, 2023
·
18 min read
Business

RadNet Reports Second Quarter Financial Results, with Record Quarterly Revenue and Adjusted EBITDA(1), and Updates 2023 Financial Guidance Ranges

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 363 owned and operated outpatient imaging centers, reported financial results for its second quarter of 2023.

August 8, 2023
·
27 min read
Business

Haemonetics 1st Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Haemonetics Corporation announced that financial results for its first quarter fiscal 2024, which ended July 1, 2023, are available on its Investor Relations website.

August 8, 2023
·
2 min read
Pharm Country

GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs

GenScript Biotech Corporation, the world’s leading provider of life-science research tools and services, has ramped up production of complex and modified peptides at its state-of-the-art cGMP manufacturing facility in Zhenjiang, China.

August 8, 2023
·
5 min read
Drug Development

OCS-01, First Investigational Eye Drop for Front and Back of the Eye, Met Both Primary Endpoints in Phase 3 OPTIMIZE Trial with a Once Daily Regimen for the Treatment of Inflammation and Pain Following Cataract Surgery

Oculis Holding AG announced positive top line results from its Phase 3 OPTIMIZE trial with OCS-01 eye drops, a novel, once-daily, high concentration, preservative-free, topical OPTIREACH® formulation of dexamethasone for the treatment of inflammation and pain following ocular surgery.

August 8, 2023
·
9 min read